SC
PFE icon

Sculptor Capital’s Pfizer PFE Stock Holding History

Sculptor Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-952,078
Closed -$26.8M – 383
2016
Q1 		$26.8M Buy
952,078
+917,943
+2,689% +$26.2M 0.14% 129
2015
Q4 		$1.04M Buy
+34,135
New +$1.07M 0.01% 287
2015
Q1 		– Sell
-19,183
Closed -$567K – 681
2014
Q4 		$567K Sell
19,183
-4,074,633
-100% -$117M ﹤0.01% 674
2014
Q3 		$115M Sell
4,093,816
-2,911,193
-42% -$81.7M 0.33% 71
2014
Q2 		$197M Buy
7,005,009
+4,886,344
+231% +$139M 0.59% 46
2014
Q1 		$64.6M Buy
2,118,665
+1,542,110
+267% +$46M 0.21% 108
2013
Q4 		$16.8M Sell
576,555
-369,451
-39% -$10.8M 0.04% 372
2013
Q3 		$25.8M Buy
+946,006
New +$25.7M 0.07% 310

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sculptor Capital's PFE Position: Q2 2016 in Review

Sculptor Capital sold out of Pfizer (PFE) in Q2 2016, closing a stake of 952,078 shares — an estimated $26.8M sold.

Sculptor Capital first reported a position in PFE in Q3 2013 and held it in 8 quarters. The position peaked at $197M in Q2 2014. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Sculptor Capital reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Sculptor Capital sold 952,078 Pfizer shares in Q2 2016, an estimated $26.8M.
  • Sculptor Capital first reported a position in Pfizer in Q3 2013 and held it in 8 quarters.
  • Sculptor Capital's Pfizer position peaked at $197M in Q2 2014.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Sculptor Capital's 13F filing for Q2 2016, filed 15 Aug 2016.